Sonnet BioTherapeutics Holdings, Inc. SONN
Set alert
1.26 0.00 0.00%
At close · Dec 2
1.26 Day range 3.23
1.26 52-week range 5.95
- YTD
- -13.70%
- 1 year
- -51.72%
- Open
- 3.16
- Prev close
- 1.26
- Mkt cap
- 8.43M
- Vol
- 10.43M
- Avg vol
- 1.25M
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.26
- High
- 3.23
- Forward P/E
- -0.10
- Beta
- 1.04
- Short ratio
- 0.03
- Inst. own
- 0.20%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 12, 2025
- 50-d avg
- 3.46
- 200-d avg
- 8.63
- 1y target
- 160.00
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 160.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -11.12 | -11.12 – -11.12 | -2.48 | -348.4% | 0 | -100.0% | 1 |
| Next quarter | -6.32 | -6.32 – -6.32 | 0.56 | -1228.6% | 0 | 0.0% | 1 |
| Current year | -27.36 | -27.36 – -27.36 | -11.35 | -141.1% | 0 | -100.0% | 1 |
| Next year | 0.00 | 0.00 – 0.00 | -27.36 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 20, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Aug 23, 2024 | Chardan Capital | Maintained | Buy | Buy |
| May 28, 2024 | Chardan Capital | Maintained | Buy | Buy |
| May 16, 2024 | EF Hutton | Maintained | Buy | Buy |
| Feb 15, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Nov 27, 2023 | Ladenburg Thalmann | Initiated | — | Buy |